ACADIA PHARMACEUTICALS INC. (ACAD) Operating income 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) annual operating income history from SEC filings — each fiscal year as reported.
$104.8MFY2025 · since FY2016: -$272.8M → $104.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $104.8M | -54.6% |
| FY2024 | $230.8M | +414.5% |
| FY2023 | -$73.4M | +67.2% |
| FY2022 | -$223.6M | -31.2% |
| FY2021 | -$170.4M | +40.5% |
| FY2020 | -$286.6M | -16.2% |
| FY2019 | -$246.5M | +0.4% |
| FY2018 | -$247.4M | +15.4% |
| FY2017 | -$292.4M | -7.2% |
| FY2016 | -$272.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice